{"id":70536,"date":"2013-06-05T15:53:19","date_gmt":"2013-06-05T14:53:19","guid":{"rendered":"https:\/\/www.strattoncraig.com\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/"},"modified":"2013-06-05T15:53:19","modified_gmt":"2013-06-05T14:53:19","slug":"nhs-reform-the-implications-for-pharmaceutical-communications","status":"publish","type":"post","link":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/","title":{"rendered":"NHS reform – the implications for pharmaceutical communications"},"content":{"rendered":"

Since the announcement of the NHS reform plans last month there has been much talk of the consequences and implications that will be felt from the departure of the NHS we know today.
\nOne discussion that particularly caught our attention was that which approached the challenges and opportunities that the reform will offer the pharmaceutical industry.
\nThere are a number of hurdles for the industry. For example, they will face strict budgetary management and the effects of clinical commissioning by GPs. In addition, pharma companies will now have to liaise with 500 GP consortia after the abolishment of Primary Care Trusts (PCT) (of which they needed only to engage with 150 pharma-savvy parties).
\nImportantly though, there are also several opportunities to be grasped here. For example, GPs will need advice on how best to approach their new commissioning roles and there will also be greater opportunities to work within the private sector.
\nWe\u2019ve only slightly touched on the many implications of the reform, but you can find out more through organisations such as Visions4Health<\/a>. In order to overcome such challenges and make the most of the opportunities, it\u2019s clear that pharmaceutical companies need to competitively position and promote themselves within the new NHS. And this inevitably starts with effective, focused and long-term communications and marketing strategies alongside clear brand articulation.
\nWe\u2019ve worked with a number of pharmaceutical organisations including GlaxoSmithKline and AstraZenica as well as the NHS and a number of independent healthcare practitioners. If you\u2019d like to speak to us about how we can help you embrace upcoming changes in the industry please contact Harriette Hobbs on 0117 9371 383 or harriette@strattoncraig.co.uk<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Since the announcement of the NHS reform plans last month there has been much talk of the consequences and implications that will be felt from the departure of the NHS we know today. One discussion that particularly caught our attention was that which approached the challenges and opportunities that the reform will offer the pharmaceutical […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[453],"tags":[],"class_list":["post-70536","post","type-post","status-publish","format-standard","hentry","category-archived-content-us"],"acf":[],"yoast_head":"\nNHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency\" \/>\n<meta property=\"og:description\" content=\"Since the announcement of the NHS reform plans last month there has been much talk of the consequences and implications that will be felt from the departure of the NHS we know today. One discussion that particularly caught our attention was that which approached the challenges and opportunities that the reform will offer the pharmaceutical […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/\" \/>\n<meta property=\"og:site_name\" content=\"Stratton Craig - Global Copywriting & Content Marketing Agency\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-05T14:53:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.strattoncraig.com\/wp-content\/uploads\/2022\/01\/stratton-craig-share.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stratton Craig\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stratton Craig\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/\"},\"author\":{\"name\":\"Stratton Craig\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/#\\\/schema\\\/person\\\/5e1a5300b8954ddf765b2a201f88e90b\"},\"headline\":\"NHS reform – the implications for pharmaceutical communications\",\"datePublished\":\"2013-06-05T14:53:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/\"},\"wordCount\":284,\"articleSection\":[\"Archive\"],\"inLanguage\":\"us-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/\",\"url\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/\",\"name\":\"NHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/#website\"},\"datePublished\":\"2013-06-05T14:53:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/#\\\/schema\\\/person\\\/5e1a5300b8954ddf765b2a201f88e90b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/#breadcrumb\"},\"inLanguage\":\"us-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/nhs-reform-the-implications-for-pharmaceutical-communications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHS reform – the implications for pharmaceutical communications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/\",\"name\":\"Stratton Craig - Global Copywriting & Content Marketing Agency\",\"description\":\"Written Communication\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"us-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/#\\\/schema\\\/person\\\/5e1a5300b8954ddf765b2a201f88e90b\",\"name\":\"Stratton Craig\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"us-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g\",\"caption\":\"Stratton Craig\"},\"url\":\"https:\\\/\\\/www.strattoncraig.com\\\/us\\\/insight\\\/author\\\/stratton-craig\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/","og_locale":"en_US","og_type":"article","og_title":"NHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency","og_description":"Since the announcement of the NHS reform plans last month there has been much talk of the consequences and implications that will be felt from the departure of the NHS we know today. One discussion that particularly caught our attention was that which approached the challenges and opportunities that the reform will offer the pharmaceutical […]","og_url":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/","og_site_name":"Stratton Craig - Global Copywriting & Content Marketing Agency","article_published_time":"2013-06-05T14:53:19+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.strattoncraig.com\/wp-content\/uploads\/2022\/01\/stratton-craig-share.jpg","type":"image\/jpeg"}],"author":"Stratton Craig","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Stratton Craig","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/#article","isPartOf":{"@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/"},"author":{"name":"Stratton Craig","@id":"https:\/\/www.strattoncraig.com\/us\/#\/schema\/person\/5e1a5300b8954ddf765b2a201f88e90b"},"headline":"NHS reform – the implications for pharmaceutical communications","datePublished":"2013-06-05T14:53:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/"},"wordCount":284,"articleSection":["Archive"],"inLanguage":"us-US"},{"@type":"WebPage","@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/","url":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/","name":"NHS reform - the implications for pharmaceutical communications - Stratton Craig - Global Copywriting & Content Marketing Agency","isPartOf":{"@id":"https:\/\/www.strattoncraig.com\/us\/#website"},"datePublished":"2013-06-05T14:53:19+00:00","author":{"@id":"https:\/\/www.strattoncraig.com\/us\/#\/schema\/person\/5e1a5300b8954ddf765b2a201f88e90b"},"breadcrumb":{"@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/#breadcrumb"},"inLanguage":"us-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.strattoncraig.com\/us\/insight\/nhs-reform-the-implications-for-pharmaceutical-communications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.strattoncraig.com\/us\/"},{"@type":"ListItem","position":2,"name":"NHS reform – the implications for pharmaceutical communications"}]},{"@type":"WebSite","@id":"https:\/\/www.strattoncraig.com\/us\/#website","url":"https:\/\/www.strattoncraig.com\/us\/","name":"Stratton Craig - Global Copywriting & Content Marketing Agency","description":"Written Communication","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.strattoncraig.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"us-US"},{"@type":"Person","@id":"https:\/\/www.strattoncraig.com\/us\/#\/schema\/person\/5e1a5300b8954ddf765b2a201f88e90b","name":"Stratton Craig","image":{"@type":"ImageObject","inLanguage":"us-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f223aed3fe97fd5e2dc17a9a2aca217e0a922a2671c4026e23049bb6ebfade15?s=96&d=mm&r=g","caption":"Stratton Craig"},"url":"https:\/\/www.strattoncraig.com\/us\/insight\/author\/stratton-craig\/"}]}},"_links":{"self":[{"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/posts\/70536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/comments?post=70536"}],"version-history":[{"count":0,"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/posts\/70536\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/media?parent=70536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/categories?post=70536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.strattoncraig.com\/us\/wp-json\/wp\/v2\/tags?post=70536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}